| Tag | Content |
|---|
EnhancerAtlas ID | HS139-43425 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr5:55469940-55471970 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| BCL6 | MA0463.2 | chr5:55469989-55470005 | TATTCCTAGAAAGAGT | - | 6.25 | | Nr2f6(var.2) | MA0728.1 | chr5:55470442-55470457 | GAGGTCAAGAGATCG | + | 6 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_09794 | chr5:55469431-55474290 | CD14 | | SE_38548 | chr5:55470681-55472087 | HUVEC | | SE_43570 | chr5:55470541-55472027 | MM1S |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH05I056174 | chr5 | 55470628 | 55473750 |
|
Enhancer Sequence | ACCACATGGT GTCCTGCTGG CAGACTCTTC TCATGCAGCC CTTAGAATAT ATTCCTAGAA 60
AGAGTTGTCT GCAAAGGTGT CAACTTTCCA GGCTCCAAGG GTGTCCATCA TTATTCACCG 120
TGATTTAGAG GAGTACTTCT TCCCAGTCCC TTGCATAGCT CTCTAGTCAA AGAAATGTAA 180
AATTTTGAAT TTTTGAACTT TGAAAGGGGG ACAGTTTGCT TTCACTACAT TCTATTTGCT 240
AGTGGCAGTC AACTTTAGAA ACCCCTTCTA TGCCCTTCCT CTACCCCCTT ATCCCAGTTT 300
TCTCTTTTCT TCAGCTCAGA CACTGGAAAA GTCCATAGCA AGAGCAGTTC TTAAGGCATG 360
TGCTAGAAGG GAGGGGGCTA GGAGGACAGC CATATGTCTG TCTGAGATAT GGGACTTCGG 420
CTAATATGCA CAGACCAGTG GCTTTTAAAC TTGATGGGCA AGTTTTTAAA AATCGCCTGG 480
GAGGCTGAGG CGGGCAGATC ATGAGGTCAA GAGATCGAGA CCATCCTGGC CAACATGGTG 540
AAACCCTGTC TCTACTAAAA ATACAAAAAT TAGCTGGGTG TGGTGGTGCA TGCCTGTAGT 600
CCCAGCTACC TGGGAGGCTA TGGCAGGAGA ATCGCTTGAA CCTGGGAGGC AGAGTCTGCA 660
GTGAGCTGAG ATCGCACCAC TGCACTCCAG CCTGGTGACA GAGTGAGACT CTGTCTCAAA 720
AAAAAAAAAA AAAAAAAAAA TTGCCAAGGA GGTTTGTTCA ACATGCAGAC TCCCCCAACA 780
CCAACTACCC CAGTCCTGCT CCCAGAGTAT CTGACTCAGA AGGTCTAGGG TATACCCCTG 840
GTACCTGCAT TTGACACTAA TGTGAATAAG TTCTGATAAC CCTCTACCAT CAGACCAGCC 900
TGGCATTTGC ATTTGAAACA AGCACCCCAA GGGATATTGA CACAAAAGAT CTGTGGACCA 960
CAGTTTGAAA ATTTCTTCCC AGATTTGCAT GTGAGTTCTA GAGAGAGAGC ACAAATAGAA 1020
AATGAAAAAG TAGGCTCTAA AGGAAATCTC TGTGAGACTT GGGCAATGCT TCATTGCAAT 1080
CTATGATAGG TCATGGCAGA AAGGGGTGGT GTTTGGGAAA GGGAAGTGAT TTAATTCAGC 1140
AGGACACCCT CAATGGGGCT GGTCCAGAGT GAATTCACCA CCATCAGTGG GCAGCAATAG 1200
CAAATGCAAG CCATAGCAAA TGCAAGAAGC TGCACTGGTA GCAATGGTGG TCATAGTGAA 1260
GATTTCTGGG TACCTCTCTG GAGAGGAAGA AAAAGGATGA CCTCCATGTG GTGGTTAGGA 1320
CTTGTTTGAC ATGGACTCAA GGCACCCCTA GGACCTCCCA AAAGGATTGC AGGAAGAGTT 1380
TGAGAGGAGA GGGTCTTGAG GATTTTCAGT AAGGCTTAAC CAGGCTTGCT CTAATGTTGG 1440
GAAATGCTGA ACTGAAATCT CTACCGGTGA GGACTAGTAT TATGACACAG TTGTTAAATT 1500
GAGCCCTGAT TGTGGGCTGA GTCATCTGCT TGGCGTTGTC CCTTTAAGAG CCTGCTTTGT 1560
CTCCCCTGTT CTTTATCTTC CAGTCCCTCC CACCACCTTC CCCAGTTCTC GTTGTTCTCC 1620
ACATTCCTTA GCCTCAAGCT TCTACTCAAC CAATCCTACC CCACAGATGT TAATTGGATC 1680
TTCACAGTAT TCCCACCCTG TTGGGGTTAT TTAGGGAGAT TGTTTTTAGA AGCACCAAGT 1740
GTGTCCAGAA ATATCCCAAG AGAAATTCTG ATGCCATTAA GATAGAAAAG AATGTTTCCC 1800
TAATGGCCAT ATCACCTCTA TCTTAGAGGA TTGTTAGGAA GATCCAAAAT GGCCCAAATT 1860
CATGAAACCA ACTCTAAGTG GGGATATAAA CGTTGAAGAT GATTGGAGTA AAGCTTCAAG 1920
TTCCAGCTCC TTTAGCCAGC TGCATAGATC CAAGAATGCT CCTTTGCAAC TGGGACCCCA 1980
TAATGACACC CTTCGCCTAC CCTGCTCCTT CCACCCTGTG ACAGGCACAA 2030
|
